International Gemological Institute Limited Q4 FY2025 Concall Summary

Source transcript PDF: https://www.stockscans.in/document/rafvnv48g0qzk4rr4lb60e0e.pdf

Key Takeaways


Volume & Revenue Dynamics

Eashwar Iyer: "With the heavy capex and the opex model that these guys, the manufacturers operate with at the \$170, \$200 of wholesale prices for lab grown stones. We estimated that their ROIs is in the 8% to 10% range. So that gives us confidence for the fact that there is not much elbow room now available for them to therefore drop prices further."

Lab-Grown Diamond Landscape


Geographic Performance

GeographyTrendCommentary
India▲ Faster than consolidatedNatural diamond loose and jewelry momentum continues QoQ; lab-grown jewelry adoption rising. India growth expected to outpace consolidated given its manufacturing dominance.
US▲ Lab-grown strengthLab-grown acceptance far ahead of other markets; most lab-grown exports flow here, driving certification volumes.
Netherlands group▲ ImprovingIncludes China, Dubai, Israel, Thailand, Hong Kong; significant traction in China and Dubai is lifting the overall entity.
Belgium▼ UnderperformingRecovering from losses but management declined to give specific margin trajectory or recovery timeline.

Tariff Exposure & Mitigation

Tehmasp Printer: "So tariff on services are correspondingly impacting less. And the value of the lab-growns in the wholesale level is low. And probably the incremental cost to the retailer, and finally to the consumer would be I think distributed between the manufacturer, the retailer, and the end consumer."

Operations & Investment

Eashwar Iyer: "We will continue to do what is right for the business because as we speak, recruitment on people, etcetera is continuing because the paramount importance for us as an organization is to ensure five star customer service."

Margins & Profitability

Eashwar Iyer: "While the Company is continuing to invest significantly in terms of building up or ramping up capabilities from a people and a laboratory expansion standpoint, we are confident that with the volume throughput that is coming through, we should therefore improve on whatever we delivered last year. So anything between 57 and 64 is what we think we will deliver from a PAT margin standpoint."

Guidance & Commitments

CommitmentSpecificsTimeline
Revenue growth matching volume growthRevenue and volume growth to mirror each other overallFrom Q3 FY25 onward
Volume growth target20%+ volume growthNext three to five years
PAT margin57% to 64%Full year FY25
Revenue and EBITDA growthIn line with historical performanceFull year FY25
Lab-grown pricing stabilityNo major correction expected going forwardOngoing; stable for last three quarters
Q2 mix seasonalityQ2 to mirror Q1 mix for both consolidated and India standaloneQ2 FY25
Jewelry segment contributionJewelry to drive significant proportion of growthComing quarters
CY24 disclosureManagement to consider sharing CY24 numbers similarlyNo date

Key Metrics

MetricQ1 CY25 (Q4 FY25)
Revenue from operations₹305 cr, +15% QoQ and +10% YoY
Certification income₹297 cr, +20% QoQ and +11% YoY
EBITDA₹196 cr, +29% QoQ and +13% YoY
EBITDA margin64.2%, improved 680 bps QoQ
PAT₹141 cr, +24% QoQ
PAT margin46.2%, expanded 330 bps QoQ
Full-year PAT margin guidance57% to 64% for CY25
Total reports (volumes)0.31 cr, +13% QoQ and +27% YoY
Average realized price per report₹950, up from ₹889 in Q4 CY24
Natural diamonds revenue growth+37% QoQ
Lab-grown diamonds revenue growth+35% QoQ and +9% YoY
Lab-grown diamond jewelry revenue growth+87% YoY
Jewelry segment revenue mix~28% of total, up from 23-24% in Q1 CY24
India revenue share of groupOver 75%
International subsidiaries EBITDA margin~20%, up from 13-14%
Gemologists recruited in India during Q1Over 130, representing ~14% of overall employee strength